Polymeric nanoparticles: potent vectors for vaccine delivery targeting cancer and infectious diseases A Bolhassani, S Javanzad, T Saleh, M Hashemi, MR Aghasadeghi, ... Human vaccines & immunotherapeutics 10 (2), 321-332, 2014 | 305 | 2014 |
HCV core protein immunization with Montanide/CpG elicits strong Th1/Th2 and long-lived CTL responses F Roohvand, MR Aghasadeghi, SM Sadat, A Budkowska, AR Khabiri Biochemical and biophysical research communications 354 (3), 641-649, 2007 | 56 | 2007 |
Inhibition of HIV and HSV infection by vaginal lactobacilli in vitro and in vivo R Zabihollahi, E Motevaseli, SM Sadat, AR Azizi-Saraji, S Asaadi-Dalaie, ... DARU Journal of Pharmaceutical Sciences 20 (1), 53, 2012 | 48 | 2012 |
Application of outer membrane vesicle of Neisseria meningitidis serogroup B as a new adjuvant to induce strongly Th1-oriented responses against HIV-1 M Reza Aghasadeghi, A Sharifat Salmani, S Mehdi Sadat, F Javadi, ... Current HIV research 9 (8), 630-635, 2011 | 41 | 2011 |
Nanosilver based anionic linear globular dendrimer with a special significant antiretroviral activity MS Ardestani, AS Fordoei, A Abdoli, RA Cohan, G Bahramali, SM Sadat, ... Journal of Materials Science: Materials in Medicine 26 (5), 179, 2015 | 37 | 2015 |
Combination of cell penetrating peptides and heterologous DNA prime/protein boost strategy enhances immune responses against HIV-1 Nef antigen in BALB/c mouse model S Kadkhodayan, BS Jafarzade, SM Sadat, F Motevalli, E Agi, ... Immunology Letters, 2017 | 32 | 2017 |
Prime/boost immunization with HIV-1 MPER-V3 fusion construct enhances humoral and cellular immune responses A Bolhassani, K Kardani, R Vahabpour, N Habibzadeh, MR Aghasadeghi, ... Immunology letters 168 (2), 366-373, 2015 | 26 | 2015 |
A comparative study of two novel nanosized radiolabeled analogues of methionine for SPECT tumor imaging AG Khosroshahi, M Amanlou, O Sabzevari, FJ Daha, MR Aghasadeghi, ... Current medicinal chemistry 20 (1), 123-133, 2013 | 23 | 2013 |
Frequency and genotype of hepatitis D virus infection in patients infected with HIV and those undergoing hemodialysis MR Aghasadeghi, M Mohraz, G Bahramali, A Aghakhani, M Banifazl, ... Hepatitis monthly 13 (5), 2013 | 21 | 2013 |
The in vitro anti-viral potential of Setarud (IMOD™), a commercial herbal medicine with protective activity against acquired immune deficiency syndrome in clinical trials R Zabihollahi, R Namazi, MR Aghasadeghi, AF Esfahani, SM Sadat, ... Indian journal of pharmacology 44 (4), 448, 2012 | 21 | 2012 |
Outer membrane vesicle ofNeisseria meningitidis serogroup B as an adjuvant to induce specific antibody response against the lipopolysaccharide ofBrucella abortus S99 AS Salmani, SD Siadat, D Norouzian, JI Mobarakeh, M Kheirandish, ... Annals of microbiology 59 (1), 145, 2009 | 21 | 2009 |
IL28B rs12980275 and HLA rs4273729 genotypes as a powerful predictor factor for rapid, early, and sustained virologic response in patients with chronic hepatitis C P Sedighimehr, S Irani, F Sakhaee, F Vaziri, M Aghasadeghi, SM Sadat, ... Archives of virology 162 (1), 181-189, 2017 | 20 | 2017 |
Generation of GFP Native Protein for Detection of Its Intracellular Uptake by Cell-Penetrating Peptides. S Kadkhodayan, SM Sadat, S Irani, F Fotouhi, A Bolhassani Folia biologica 62 (3), 103-109, 2016 | 19 | 2016 |
Construction and Immunogenicity Analysis of Hepatitis C Virus (HCV) Truncated Non-Structural Protein 3 (NS3) Plasmid Vaccine MH Pouriayevali, T Bamdad, MR Aghasadeghi, SM Sadat, F Sabahi Jundishapur journal of microbiology 9 (3), 2016 | 18 | 2016 |
Recombinant PBP2a as a vaccine candidate against methicillin-resistant Staphylococcus aureus: Immunogenicity and protectivity S Haghighat, SD Siadat, SMR Sorkhabadi, AA Sepahi, SM Sadat, ... Microbial Pathogenesis 108, 32-39, 2017 | 16 | 2017 |
Hp91 immunoadjuvant: An HMGB1-derived peptide for development of therapeutic HPV vaccines S Talebi, A Bolhassani, SM Sadat, R Vahabpour, E Agi, S Shahbazi Biomedicine & Pharmacotherapy 85, 148-154, 2017 | 16 | 2017 |
Genotyping of human parechoviruses in Iranian young children with aseptic meningitis and sepsis-like illness P Rahimi, HM Naser, SD Siadat, A Sohrabi, E Mostafavi, M MotamediRad, ... Journal of neurovirology 19 (6), 595-600, 2013 | 16 | 2013 |
EXPRESSION AND CHARACTERIZATION OF Escherichia coli DERIVED HEPATITIS C VIRUS ARFP/F PROTEIN F Baghbani-Arani, F Roohvand, MR Aghasadeghi, A Eidi, S Amini, ... Молекулярная биология 46 (2), 251-251, 2012 | 16 | 2012 |
Application of SCR priming VLP boosting as a novel vaccination strategy against HIV-1 S Mehdi Sadat, R Zabihollahi, M Reza Aghasadeghi, R Vahabpour, ... Current HIV research 9 (3), 140-147, 2011 | 15 | 2011 |
Delivery of HIV-1 Nef protein in mammalian cells using cell penetrating peptides as a candidate therapeutic vaccine BS Jafarzade, A Bolhassani, SM Sadat, R Yaghobi International Journal of Peptide Research and Therapeutics 23 (1), 145-153, 2017 | 13 | 2017 |